Reducing liver function tests for statin monitoring: an observational comparison of two clinical commissioning groups

Abstract

This simple and generalisable intervention, enabling ordering of a single ALT combined with information recommending prudent rather than periodic testing, reduced full LFT testing by 24.3% in people on statins. This is likely to have patient benefit at reduced cost.